SH3PXD2A and non-small cell lung carcinoma: Moreover, highly expressed SH3PXD2A-AS1 exhibited lower survival in LUAD and LUSC patients (Fig. 1C), while SH3PXD2A-AS1 expression was upregulated in A549 and H1299 resistant cell lines compared with A549 and H1299 sensitive cell lines (Fig. 1D), implying the important role of SH3PXD2A-AS1 in DDP-resistance in NSCLC.